Surface Oncology to Present at Goldman Sachs 39th Annual Global Healthcare Conference

On June 8, 2018 Surface Oncology (NASDAQ:SURF), a clinical-stage immuno-oncology company developing next-generation immunotherapies that target the tumor microenvironment, reported that Chief Executive Officer Jeff Goater will present at the Goldman Sachs 39th Annual Global Healthcare Conference in Rancho Palos Verdes, California on Wednesday, June 13th at 3:20 p.m. Pacific time (Press release, Surface Oncology, JUN 8, 2018, View Source [SID1234527442]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

A live webcast of the discussion will be accessible through Surface Oncology’s Investor Relations website at investors.surfaceoncology.com. A replay of the webcast will be archived on Surface Oncology’s website for 30 days following the presentation.